It’s the end of an era as Tess Daly and Claudia Winkleman have announced they are set to leave Strictly Come Dancing at the ...

Citing innovation, depth, and AI-driven intelligence, GEP SMART ranked as the highest-rated solution suite for the ninth consecutive report. GEP outscored 115 other solution providers in intake and ...

Smart Pocket is announcing the official debut of its SP token, the base currency to power its growing economy based around ...

Marks and Spencer customers have been praising a sophisticated autumn coat that they claim 'looks more expensive than it is'. The M&S Collection Cotton Rich Stormwear Car Coat is £65 and comes in two ...

Finnish health tech company Oura has raised $900 million in fresh funding led by Fidelity Management & Research Company, with participation from new investor ICONIQ and contributions from Whale Rock ...

In another loss for early smart home adopters, Logitech has announced that it will brick all Pop switches on October 15. In August of 2016, Logitech launched Pop switches, which provide quick access ...

Kirby Smart and No. 10 Georgia escaped Auburn with a 20-10 win on Saturday after some very questionable calls went their way against their unranked rivals. Tigers coach Hugh Freeze was irate as the ...

Google has announced the latest generation of Nest cams with upgraded features, plus sweeping changes that make Gemini for Home the foundation of its home tech. Tyler Lacoma Editor / Home Security For ...

Want more deals? Visit CNN Underscored’s Guide to Prime Big Deal Days for wall-to-wall coverage of the best discounts to be found during Amazon’s massive sale. In addition to being a stellar discount ...

Every time Steven publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Sanofi SA (NASDAQ:SNY) on Wednesday released topline data from a phase 2 study evaluating the efficacy and safety of AlphaMedix (212Pb-DOTAMTATE). The patients had unresectable or metastatic ...

Sanofi has said its radioligand therapy (RLT) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) hit all its objectives in a phase 2 study, setting up possible regulatory filings. The ...